Teva Pharmaceutical Industries Limited

TEVA | NYSE

Price Alert Chart Builder DCF Calculator

$39.35

-$0.71 (-1.77%)

Sep 22, 2026, 1:03 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	17.31B	17.35B	17.26B	16.78B	16.63B	16.62B	16.54B	16.77B	16.29B	16B	15.85B	15.27B	15.02B	14.93B	14.93B	15.14B	15.43B	15.56B	15.88B	16.23B	16.32B	16.28B
Cost of Revenue	8.23B	8.32B	8.32B	8.37B	8.38B	8.45B	8.48B	8.41B	8.23B	8.17B	8.2B	8.27B	8.2B	8.11B	7.95B	7.89B	8.06B	8.1B	8.28B	8.64B	8.67B	8.74B
Gross Profit	9.09B	9.03B	8.94B	8.4B	8.25B	8.17B	8.06B	8.36B	8.06B	7.83B	7.65B	7B	6.82B	6.82B	6.97B	7.25B	7.38B	7.46B	7.6B	7.59B	7.65B	7.54B
Operating Income	1.98B	2.29B	2.16B	1.83B	894M	434M	-303M	482M	877M	228M	433M	-1.18B	-1.1B	-1.4B	-2.1B	-1.17B	-961M	570M	1.72B	2.05B	-2.92B	-3.33B
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	720M	1.38B	1.24B	899M	-70M	-518M	-1.28B	-528M	-143M	-790M	-553M	-2.16B	-2.06B	-528M	-1.24B	-319M	-105M	-427M	670M	1.03B	-3.67B	-4.04B
Net Income	706M	1.56B	1.41B	712M	-158M	-1.29B	-1.64B	-959M	-453M	-479M	-560M	-2.24B	-2.26B	-1.62B	-2.35B	-1.29B	-1.05B	-615M	417M	726M	-3.92B	-3.98B
Selling & General & Admin	4.13B	4.05B	3.97B	3.8B	3.75B	3.73B	3.7B	3.65B	3.57B	3.54B	3.5B	3.43B	3.41B	3.41B	3.45B	3.52B	3.58B	3.53B	3.53B	3.63B	3.63B	3.63B
Research & Development	995M	989M	1.01B	1.02B	1B	1.03B	1.02B	985M	998M	1B	1.02B	991M	913M	866M	838M	872M	919M	939M	968M	1.11B	1.14B	1.12B
Other Expenses	1.98B	1.7B	1.8B	1.76B	2.6B	2.97B	3.64B	3.24B	2.62B	3.06B	2.7B	3.75B	3.6B	3.94B	4.79B	4.03B	3.84B	2.42B	1.38B	812M	5.8B	6.12B
Operating Expenses	7.1B	6.74B	6.78B	6.58B	7.35B	7.74B	8.37B	7.88B	7.19B	7.61B	7.21B	8.18B	7.92B	8.21B	9.07B	8.42B	8.34B	6.89B	5.88B	5.55B	10.57B	10.87B
Interest Expense	902M	905M	929M	-126M	-63M	-25M	n/a	1.02B	1.03B	1.06B	1.07B	1.09B	1.06B	1B	1B	901M	890M	953M	985M	1.2B	1.08B	1.03B
Selling & Marketing Expenses	2.82B	2.76B	2.69B	2.58B	2.55B	2.55B	2.54B	2.5B	2.45B	2.4B	2.34B	2.27B	2.24B	2.23B	2.27B	2.35B	2.41B	2.43B	2.43B	2.48B	2.49B	2.47B
Cost & Expenses	15.33B	15.06B	15.1B	14.95B	15.73B	16.18B	16.85B	16.29B	15.41B	15.78B	15.41B	16.45B	16.12B	16.32B	17.02B	16.31B	16.4B	14.99B	14.16B	14.19B	19.24B	19.61B
Income Tax Expense	12M	-187M	-180M	238M	93M	801M	675M	688M	607M	-7M	64M	177M	296M	1.18B	1.16B	985M	954M	152M	212M	257M	197M	-5M
Shares Outstanding (Basic)	1.17B	1.16B	1.15B	1.15B	1.15B	1.14B	1.13B	1.13B	1.13B	1.12B	1.12B	1.12B	1.12B	1.12B	1.11B	1.11B	1.11B	1.11B	1.1B	1.1B	1.1B	1.1B
Shares Outstanding (Diluted)	1.18B	1.18B	1.17B	1.16B	1.16B	1.16B	1.13B	1.13B	1.13B	1.12B	1.14B	1.14B	1.12B	1.12B	1.11B	1.12B	1.11B	1.11B	1.1B	1.11B	1.11B	1.11B
EPS (Basic)	0.63	1.37	1.24	0.63	-0.14	-1.13	-1.45	-0.85	-0.39	-0.42	-0.49	-2	-2.02	-1.46	-2.12	-1.16	-0.95	-0.55	0.38	0.66	-3.57	-3.63
EPS (Diluted)	0.60	1.33	1.20	0.60	-0.16	-1.14	-1.45	-0.85	-0.39	-0.42	-0.49	-2	-2.02	-1.46	-2.12	-1.16	-0.95	-0.55	0.38	0.66	-3.57	-3.63
EBITDA	3.01B	3.27B	3.35B	3.88B	2.98B	2.57B	1.67B	2.03B	2.45B	3.17B	3.92B	1.81B	1.93B	1.97B	793M	1.61B	1.91B	1.8B	2.98B	3.86B	-1.14B	-1.48B
EBIT	2.01B	2.27B	2.34B	2.86B	1.96B	1.54B	611M	969M	1.37B	2.05B	2.76B	621M	695M	676M	-515M	288M	580M	522M	1.65B	2.46B	-2.59B	-3.01B
Depreciation & Amortization	998M	999M	1B	1.01B	1.02B	1.03B	1.06B	1.06B	1.08B	1.12B	1.15B	1.19B	1.23B	1.29B	1.31B	1.32B	1.33B	1.28B	1.33B	1.41B	1.46B	1.53B